ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2,1,Cortisol decreased,Adrenal cortex tests,Endocrine investigations (incl sex hormones),Inv,N
2,2,Hirsutism,Hypertrichoses,Skin appendage conditions,Skin,N
2,3,Product contamination chemical,Product contamination and sterility issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2,4,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
3,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
